We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
-2.2%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$169M
AUM Growth
-$4.66M
Cap. Flow
+$2.74M
Cap. Flow %
1.62%
Top 10 Hldgs %
73.61%
Holding
610
New
35
Increased
156
Reduced
72
Closed
36

Top Buys

Rank Stock Value
1
ANAB icon
AnaptysBio
ANAB
+$1.53M
2
CNTA
Centessa Pharmaceuticals
CNTA
+$1.14M
3
AXGN icon
Axogen
AXGN
+$586K
4
TSLA icon
Tesla
TSLA
+$504K
5
PLRX icon
Pliant Therapeutics
PLRX
+$501K

Top Sells

Rank Stock Value
1
FNA
Paragon 28, Inc.
FNA
+$1.36M
2
NVDA icon
NVIDIA
NVDA
+$517K
3
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$409K
4
IWM icon
iShares Russell 2000 ETF
IWM
+$252K
5
PYCR
Paycor HCM, Inc. Common Stock
PYCR
+$144K

Sector Composition

Rank Sector Weight
1 Healthcare 15.33%
2 Financials 5.86%
3 Technology 3.53%
4 Industrials 1.51%
5 Consumer Discretionary 1.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLUG icon
551
Plug Power
PLUG
$2.87B
$203 ﹤0.01%
150
-50
-25% -$95
ARAY icon
552
Accuray
ARAY
$32M
$179 ﹤0.01%
100
– –
USIG icon
553
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
$177 ﹤0.01%
3
– –
TSM icon
554
TSMC
TSM
$2.1T
$166 ﹤0.01%
+1
New +$194
FUBO icon
555
FuboTV Inc
FUBO
$261M
$146 ﹤0.01%
4
– –
STRO icon
556
Sutro Biopharma
STRO
$401M
$146 ﹤0.01%
23
-202
-90% -$3.18K
GNPX icon
557
Genprex
GNPX
$3.02M
– –
0
– –
IBRX icon
558
ImmunityBio
IBRX
$7.51B
$120 ﹤0.01%
40
– –
CGC
559
Canopy Growth
CGC
$387M
$118 ﹤0.01%
130
– –
BIL icon
560
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$47.1B
$104 ﹤0.01%
1
– –
IBLC icon
561
iShares Blockchain and Tech ETF
IBLC
$80.2M
$99 ﹤0.01%
4
– –
WW
562
DELISTED
WW International
WW
$84 ﹤0.01%
160
– –
CRNC icon
563
Cerence
CRNC
$385M
$79 ﹤0.01%
10
– –
ADAP
564
DELISTED
Adaptimmune Therapeutics
ADAP
$57 ﹤0.01%
287
– –
BLUE
565
DELISTED
bluebird bio
BLUE
$54 ﹤0.01%
11
– –
NBIS
566
Nebius Group N.V.
NBIS
$48.3B
$44 ﹤0.01%
+2
New +$66
XFOR icon
567
X4 Pharmaceuticals
XFOR
$375M
$43 ﹤0.01%
6
– –
BN icon
568
Brookfield
BN
$104B
$42 ﹤0.01%
2
– –
ICU icon
569
SeaStar Medical
ICU
$12.5M
$33 ﹤0.01%
2
– –
SLVO icon
570
Credit Suisse X-Links Silver Shares Covered Call ETNs due April 21 2033
SLVO
$11.3M
– –
0
– –
APTO
571
DELISTED
Aptose Biosciences, Inc.
APTO
$28 ﹤0.01%
9
-1
-10% -$5
JPM icon
572
JPMorgan Chase
JPM
$935B
– –
0
– –
PTEN icon
573
Patterson-UTI
PTEN
$3.98B
$6 ﹤0.01%
1
– –
ULTA icon
574
Ulta Beauty
ULTA
$22B
– –
0
– –
BP icon
575
BP
BP
$116B
– –
-39
Closed -$1.15K
21 22
23
24 25

Similar funds

IRP
Investment Research Partners Lemont, Pennsylvania $246M AUM
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
VPA
Vernal Point Advisors San Francisco, California $246M AUM 12.97% 1-Year Est. Return
KC
Kinloch Capital Glen Allen, Virginia $245M AUM 18.26% 1-Year Est. Return
HA
Hanover Advisors Seneca, South Carolina $246M AUM 12.74% 1-Year Est. Return

HighMark Wealth Management's Q1 2025 Portfolio in Review

As of Q1 2025, HighMark Wealth Management held 610 positions worth $169M, down 2.7% from $174M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

HighMark Wealth Management's Q1 2025 filing shows 35 new, 156 increased, 72 reduced and 36 closed positions. Its largest new stake was AnaptysBio: 92,000 shares worth $1.71M. The largest sale was Paragon 28, Inc., an estimated $1.36M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Financials and Technology.

  • HighMark Wealth Management's largest Q1 2025 buy was AnaptysBio: 92,000 shares worth $1.71M.
  • HighMark Wealth Management added most to Centessa Pharmaceuticals in Q1 2025, an estimated $1.14M increase.
  • HighMark Wealth Management's biggest Q1 2025 reduction was Paragon 28, Inc., cutting an estimated $1.36M.
  • HighMark Wealth Management fully exited Paycor HCM, Inc. Common Stock in Q1 2025, selling an estimated $144K.
  • HighMark Wealth Management's ten largest holdings make up 74% of its $169M portfolio in Q1 2025.
  • HighMark Wealth Management opened 35 new positions and closed 36 in Q1 2025.
  • HighMark Wealth Management's portfolio value fell 2.7% quarter-over-quarter to $169M.

Based on HighMark Wealth Management's 13F filing for Q1 2025, filed 24 Apr 2025.